T. Rowe Price Associates
MYO icon

T. Rowe Price Associates’s Myomo MYO Stock Holding History

T. Rowe Price Associates’s Portfolio MYO Stock Details MYO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$12K Hold
16,564
– – ﹤0.01% 3127
2025
Q4 		$16K Hold
16,564
– – ﹤0.01% 3081
2025
Q3 		$15K Hold
16,564
– – ﹤0.01% 3040
2025
Q2 		$36K Buy
+16,564
New +$60K ﹤0.01% 3030

Other funds holding MYO

RA
Rosalind Advisors Toronto, Ontario, Canada $249M AUM 80.12% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
JFG
Jefferies Financial Group New York $14.6B AUM 40.95% 1-Year Est. Return
CA
Clearstead Advisors Cleveland, Ohio $10.9B AUM 18.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

T. Rowe Price Associates's MYO Position: Q1 2026 in Review

T. Rowe Price Associates held its Myomo (MYO) position steady in Q1 2026 at 16,564 shares worth $12K. The position accounts for ﹤0.01% of the portfolio, ranked #3127.

T. Rowe Price Associates first reported a position in MYO in Q2 2025 and has held it in 4 quarters since. The position peaked at $36K in Q2 2025. 80 funds tracked by Wall St. Rank hold MYO as of Q1 2026.

  • T. Rowe Price Associates held 16,564 shares of Myomo worth $12K as of Q1 2026.
  • T. Rowe Price Associates left its Myomo share count unchanged in Q1 2026.
  • Myomo made up ﹤0.01% of T. Rowe Price Associates's portfolio in Q1 2026, its #3127 holding.
  • T. Rowe Price Associates first reported a position in Myomo in Q2 2025 and has held it in 4 quarters since.
  • T. Rowe Price Associates's Myomo position peaked at $36K in Q2 2025.
  • 80 funds tracked by Wall St. Rank held Myomo as of Q1 2026.

Based on T. Rowe Price Associates's 13F filing for Q1 2026, filed 15 May 2026.